Clinical Trials Directory

Trials / Completed

CompletedNCT04346173

Palatal Lengthening Using Buccinator Myomucosal Flaps with Furlow Z-plasty Technique for Primary Cleft Palate Repair

Palatal Lengthening Using Buccinator Myomucosal Flaps with Furlow Z-plasty Technique for Primary Cleft Palate Repair (A Clinical Study)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Mahmoud Akram · Academic / Other
Sex
All
Age
9 Months – 18 Months
Healthy volunteers
Not accepted

Summary

: Cleft palate is a congenital deformity caused by abnormal facial development during intra-uterine life. Worldwide, the prevalence of cleft lip/palate is about 1:1000 live births. The levator vela palatini muscles are malpositioned sagittally, running postero-anteriorly and inserted onto the posterior edge of the hard palate in cleft palate patients . This configuration prevents the muscle from exerting its upward, backward, and lateral pull. Various modalities have been described with major refinements over the past 30 years. Gradually, cleft surgeons began to appreciate the importance of dissection and retro-positioning of the levator muscle on improving speech outcomes. Furlow was the first to describe the palatoplasty technique, in which the levator muscle is dissected and freely released from its abnormal position and retro-positioned in a Z-plasty lengthening technique without dissection on the hard palate. However , among the problems that have been raised concerning the Furlow palatoplasty is the limitation of the procedure in wide clefts. Furthermore, the possibility of higher fistula rate associated with the technique. These considerations have led to modified palatal lengthening by buccinator myomucosal flaps which is this study working on.

Conditions

Interventions

TypeNameDescription
PROCEDUREfurlow z plasty with buccinator myomucosal flapusing furlow palatoplasty technique accompanied with addition of buccinator myomucosal flap for closure of primary unilateral cleft palate

Timeline

Start date
2018-07-01
Primary completion
2020-01-01
Completion
2020-03-01
First posted
2020-04-15
Last updated
2024-10-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04346173. Inclusion in this directory is not an endorsement.